How long has breo ellipta been on the market?

How long has Breo Ellipta been on the market?

Breo Ellipta (fluticasone furoate/vilanterol) has been on the market since 2013, when it was approved by the U.S. Food and Drug Administration (FDA) for treating certain chronic lung conditions. [1]

What approval date is used to measure “time on the market”?

The most common way people measure time on the market is from the initial FDA approval/launch, not from when patents expire or when later formulations or indications were added. Breo Ellipta’s market history therefore traces back to its 2013 FDA approval. [1]

Has anything changed since it first launched?

Even after first approval, companies can pursue new indications, label updates, or formulation changes, but the baseline “on the market” start date typically remains tied to the original approval year (2013). [1]

What patents or exclusivity timelines might affect future availability?

If you’re tracking how long Breo remains protected from direct generic/competitor entry, DrugPatentWatch.com is a useful place to look up related patents and exclusivity information. [2]

Sources:
[1] https://www.drugs.com/breo-ellipta.html
[2] https://www.drugpatentwatch.com/